100
Participants
Start Date
March 31, 2005
Primary Completion Date
May 31, 2006
Study Completion Date
May 31, 2006
Nitazoxanide
Nitazoxanide Oral Suspension 100 mg/5 ml for patients aged 1-3 years twice daily for 3 days or Nitazoxanide Oral Suspension 200 mg/10 ml for patients aged 4-11 years twice daily for 3 days
Regional Hospital of Cajamarca, Cajamarca
Romark Laboratories L.C.
INDUSTRY